Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482610 · ClinicalTrials.gov registry record · NA
Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat
A NA study of PreDiabetes, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT02482610 is a NA study of PreDiabetes that has completed, run by Ohio State University. The registered enrollment target is 22 participants, below the 691-participant average among 89 other PreDiabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02482610, a NA study of PreDiabetes, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods in the diet that might increase CVD risk is unclear. Further controversial is the extent to which dietary fat derived from dairy foods regulate the risk of CVD. The health benefits of dairy on CVD risk are at least partly attributed to its ability to limit PPH and resulting PPH-mediated responses leading to vascular dysfunction. This provides rationale to investigate full-fat containing dairy as a dietary strategy to reduce PPH and risk for heart disease. The objective of this project is to define the extent to which full-fat dairy milk compared to non-fat dairy milk protects against PPH-induced vascular dysfunction by reducing oxidative stress responses that limit nitric oxide bioavailability to the vascular endothelium in adults with prediabetes.
Conditions Studied
Interventions
- OTHER Glucose
- OTHER Glucose with Whole Fat Milk
- OTHER Glucose with Non-fat Milk
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482610
The ClinicalTrials.gov registry entry for NCT02482610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 691-participant average among 89 other PreDiabetes trials with a reported enrollment target (97% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 3 interventions - of which Glucose is the first listed.
NCT02482610 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02482610 about?
NCT02482610 is a clinical study titled "Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat". Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function and increase the risk of CVD. Greater intakes of dairy foods have been associated with a lower risk of CVD, but whet...
What is the current status of trial NCT02482610?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-06. Estimated completion is 2018-03.
What conditions does trial NCT02482610 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT02482610?
The interventions under investigation include: Glucose (OTHER), Glucose with Whole Fat Milk (OTHER), Glucose with Non-fat Milk (OTHER).
Who is sponsoring clinical trial NCT02482610?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02482610 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.